NTRA Oct 2024 110.000 call
| Previous close | 12.67 |
| Open | 12.60 |
| Bid | 11.10 |
| Ask | 15.20 |
| Strike | 110.00 |
| Expiry date | 2024-10-18 |
| Day's range | 12.60 - 13.13 |
| Contract range | N/A |
| Volume | |
| Open interest | 15 |
Business WireNatera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024
AUSTIN, Texas, May 30, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that the company will present new data on its Prospera donor-derived cfDNA (dd-cfDNA) test at the American Transplant Congress (ATC) 2024 taking place June 1–5, 2024.
Business WireNatera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference
AUSTIN, Texas, May 23, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that members of Natera’s management will present at the 2024 Leerink Partners Healthcare Crossroads Conference on Thursday, May 30, 2024 at 8:40 a.m. PT (11:40 a.m. ET).
Business WireNatera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting
AUSTIN, Texas, May 23, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that the company, along with its collaborators, will present new data at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 31 – June 4, 2024.
